Skip to content
Triangle logo TriangleGet started
← Full study record

NCT01319422 · OUTCOME

To Correlate Drug Induced Changes in F Actin With Cytokine Profile.

Continuous Versus Intermittent Dosing Regimens for Pomalidomide in Relapsed/Refractory Multiple Myeloma · Source last updated 2016-08-11

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

Measure
Not reported
Unit
Not reported
Interval / dispersion
Not reported
Time frame
Research blood draw will be obtained at baseline, and at 2-4 hr (on day 1), 1 wk, and 4 wk after initiation of cycles 1 and 2.

What was measured

Correlation to be determined upon completion of study treatment

Analysis population: The actin polymerization assay that was to be used for this outcome was not reproducible; hence, the cytokine profile of actin polymerized cells could not be pursued. Data were not analyzed.

Groups in this outcome

Pomalidomide 2 mg/d on 28 Days/28 Day Cycle

Pomalidomide: Comparison of different dosages and schedules of drug

Pomalidomide 4 mg/d on 21 Days/28 Day Cycle

Pomalidomide: Comparison of different dosages and schedules of drug

Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.

Analysis denominator · Participants

GroupSource count
Pomalidomide 2 mg/d on 28 Days/28 Day Cycle0
Pomalidomide 4 mg/d on 21 Days/28 Day Cycle0

Reported measurements

No numerical measurement classes were posted for this outcome. Missing is not zero.

Complete source fields
denoms
  1. counts
    1. group Id
      OG000
      value
      0
    2. group Id
      OG001
      value
      0
    units
    Participants
description
Correlation to be determined upon completion of study treatment
groups
  1. description
    Pomalidomide: Comparison of different dosages and schedules of drug
    id
    OG000
    title
    Pomalidomide 2 mg/d on 28 Days/28 Day Cycle
  2. description
    Pomalidomide: Comparison of different dosages and schedules of drug
    id
    OG001
    title
    Pomalidomide 4 mg/d on 21 Days/28 Day Cycle
population Description
The actin polymerization assay that was to be used for this outcome was not reproducible; hence, the cytokine profile of actin polymerized cells could not be pursued. Data were not analyzed.
reporting Status
POSTED
time Frame
Research blood draw will be obtained at baseline, and at 2-4 hr (on day 1), 1 wk, and 4 wk after initiation of cycles 1 and 2.
title
To Correlate Drug Induced Changes in F Actin With Cytokine Profile.
type
SECONDARY

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice